BIOVENTUS INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
BIOVENTUS INC. (BVS) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $9.26 per share for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-05
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-28 was $12.01, a 6.90% decline year-over-year.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-03-29 was $12.90, a 2.38% increase year-over-year.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-30 was $12.60, a 0.08% decline year-over-year.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-04-01 was $12.61, a 3.67% decline year-over-year.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $12.02, a 29.81% increase from fiscal 2024.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $9.26, a 21.53% decline from fiscal 2023.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $11.80, a 4.68% decline from fiscal 2022.
- BIOVENTUS INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $12.38, a 4.77% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-27 | $9.26 10-Q · filed 2026-08-05 | |||
| 2026-03-28 | $12.01 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | $12.02 10-K · filed 2026-03-05 | |||
| 2025-09-27 | $12.00 10-Q · filed 2025-11-04 | |||
| 2025-06-28 | $12.93 10-Q · filed 2025-08-06 | |||
| 2025-03-29 | $12.90 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | $9.26 10-K · filed 2026-03-05 | |||
| 2024-09-28 | $10.45 10-Q · filed 2024-11-05 | |||
| 2024-06-29 | $10.51 10-Q · filed 2024-08-06 | |||
| 2024-03-30 | $12.60 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $11.80 10-K · filed 2025-03-11 | |||
| 2023-09-30 | $12.44 10-Q · filed 2023-11-07 | |||
| 2023-07-01 | $12.36 10-Q · filed 2023-08-08 | |||
| 2023-04-01 | $12.61 10-Q · filed 2023-05-16 | |||
| 2022-12-31 | $12.38 10-K · filed 2024-03-12 | |||
| 2022-10-01 | $12.79 10-Q · filed 2022-11-21 | |||
| 2022-07-02 | $13.01 10-Q · filed 2022-08-12 | |||
| 2022-04-02 | $13.09 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | $13.00 10-K · filed 2023-03-31 | |||
| 2021-10-02 | $13.00 10-Q · filed 2021-11-10 |